Equities

Zeria Pharmaceutical Co Ltd

4559:TYO

Zeria Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,217.00
  • Today's Change-38.00 / -1.69%
  • Shares traded91.70k
  • 1 Year change+16.07%
  • Beta0.2840
Data delayed at least 20 minutes, as of Nov 08 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue75,72568,38359,533
OPERATING EXPENSES
Cost of revenue total20,22418,89517,385
Selling, general and admin. expenses, total36,83332,64630,993
Depreciation/amortization5,7974,371--
Unusual expense(income)(971)329232
Other operating expenses, total0.000.000.00
Total operating expense65,61059,69753,399
Operating income10,1158,6866,134
Other, net169225.59
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes9,5087,2735,722
Provision for income taxes1,8131,0661,747
Net income after taxes7,6956,2073,975
Minority interest36(11)(14)
Net income before extra. Items7,7316,1963,961
Total extraordinary items------
Net income7,7316,1963,961
Inc.avail. to common excl. extra. Items7,7316,1963,961
Inc.avail. to common incl. extra. Items7,7316,1963,961
EPS RECONCILIATION
Basic/primary weighted average shares444445
Basic/primary eps excl. extra items17514088
Basic/primary eps incl. extra items17514088
Dilution adjustment------
Diluted weighted average shares444445
Diluted eps excl. extra items17514088
Diluted eps incl. extra items17514088
COMMON STOCK DIVIDENDS
DPS - common stock primary issue444035
Gross dividend - common stock1,9401,7641,566
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental458337315
SUPPLEMENTAL INCOME
Depreciation, supplemental6,3415,4314,701
Total special items2421,044928
NORMALISED INCOME
Normalized income before taxes9,7508,3176,650
Effect of special items on income taxes(185)4870
Income tax excluding impact of special items1,6281,1141,817
Normalized income after tax8,1227,2034,833
Normalized income avail. to common8,1587,1924,820
Basic normalized EPS185163107
Diluted normalized EPS185163107
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.